Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Stellantis
STLA
|
+$292M |
| 2 |
Constellation Brands
STZ
|
+$288M |
| 3 |
VMW
VMware, Inc
VMW
|
+$273M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
+$261M |
| 5 |
NiSource
NI
|
+$240M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.05B |
| 2 |
Apple
AAPL
|
+$1.81B |
| 3 |
UnitedHealth
UNH
|
+$1.01B |
| 4 |
Exxon Mobil
XOM
|
+$862M |
| 5 |
Tesla
TSLA
|
+$834M |
Sector Composition
| 1 | Technology | 27.58% |
| 2 | Consumer Discretionary | 11.38% |
| 3 | Healthcare | 10.81% |
| 4 | Financials | 10.71% |
| 5 | Communication Services | 6.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1301
US Foods
USFD
$18B
| $3.26M | ﹤0.01% |
88,171
-148,144
| -63% | -$5.47M |
|
1302
Veracyte
VCYT
$2.51B
| $3.25M | ﹤0.01% |
145,703
-29,896
| -17% | -$667K |
|
1303
Novavax
NVAX
$1.34B
| $3.24M | ﹤0.01% |
467,948
+481
| +0.1% | +$3.33K |
|
1304
VanEck Junior Gold Miners ETF
GDXJ
$7.55B
| $3.24M | ﹤0.01% |
82,020
-95,375
| -54% | -$3.77M |
|
|
BDN
1305
Brandywine Realty Trust
BDN
$782M
| $3.22M | ﹤0.01% |
680,395
-129,986
| -16% | -$615K |
|
1306
Timken Company
TKR
$5.51B
| $3.22M | ﹤0.01% |
39,392
-9,742
| -20% | -$796K |
|
1307
EastGroup Properties
EGP
$8.94B
| $3.22M | ﹤0.01% |
19,457
-14,641
| -43% | -$2.42M |
|
1308
Catalyst Pharmaceutical
CPRX
$2.48B
| $3.21M | ﹤0.01% |
193,839
-97,614
| -33% | -$1.62M |
|
1309
Chegg
CHGG
$173M
| $3.21M | ﹤0.01% |
197,018
-139,706
| -41% | -$2.28M |
|
1310
Revolution Medicines
RVMD
$8.64B
| $3.21M | ﹤0.01% |
147,949
+5,950
| +4% | +$129K |
|
1311
Relay Therapeutics
RLAY
$710M
| $3.2M | ﹤0.01% |
194,470
-77,369
| -28% | -$1.27M |
|
1312
Thor Industries
THO
$5.83B
| $3.2M | ﹤0.01% |
40,223
+8,630
| +27% | +$687K |
|
1313
Advanced Energy
AEIS
$6.02B
| $3.2M | ﹤0.01% |
32,641
+14,508
| +80% | +$1.42M |
|
1314
Liberty Global Class C
LBTYK
$4.13B
| $3.2M | ﹤0.01% |
156,837
-50,362
| -24% | -$1.03M |
|
1315
Radian Group
RDN
$4.81B
| $3.19M | ﹤0.01% |
144,416
-9,456
| -6% | -$209K |
|
1316
Cable One
CABO
$1B
| $3.18M | ﹤0.01% |
4,534
+83
| +2% | +$58.3K |
|
1317
Evercore
EVR
$13.3B
| $3.18M | ﹤0.01% |
27,600
-1,121
| -4% | -$129K |
|
1318
FibroGen
FGEN
$50.3M
| $3.18M | ﹤0.01% |
6,827
-1,273
| -16% | -$594K |
|
1319
Fox Factory Holding Corp
FOXF
$1.2B
| $3.18M | ﹤0.01% |
26,239
+9,439
| +56% | +$1.15M |
|
1320
Commerce Bancshares
CBSH
$8.02B
| $3.18M | ﹤0.01% |
60,093
+26,261
| +78% | +$1.39M |
|
1321
Bloom Energy
BE
$15.7B
| $3.17M | ﹤0.01% |
159,277
-3,892
| -2% | -$77.6K |
|
1322
Stepan Co
SCL
$1.12B
| $3.17M | ﹤0.01% |
30,786
+1,481
| +5% | +$153K |
|
1323
Valaris
VAL
$3.76B
| $3.17M | ﹤0.01% |
48,696
+29,916
| +159% | +$1.95M |
|
1324
FNB Corp
FNB
$5.9B
| $3.16M | ﹤0.01% |
272,719
+119,072
| +77% | +$1.38M |
|
1325
Andersons Inc
ANDE
$1.4B
| $3.16M | ﹤0.01% |
76,538
+48,357
| +172% | +$2M |
|